Campbells Co (CPB) concluded trading on Wednesday at a closing price of $31.18, with 6.48 million shares of worth about $201.99 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -25.01% during that period and on June 25, 2025 the price saw a loss of about -3.08%. Currently the company’s common shares owned by public are about 298.00M shares, out of which, 196.40M shares are available for trading.
Stock saw a price change of -2.01% in past 5 days and over the past one month there was a price change of -6.93%. Year-to-date (YTD), CPB shares are showing a performance of -29.95% which decreased to -25.55% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $31.58 but also hit the highest price of $52.81 during that period. The average intraday trading volume for Campbells Co shares is 3.87 million. The stock is currently trading -6.14% below its 20-day simple moving average (SMA20), while that difference is down -10.50% for SMA50 and it goes to -23.87% lower than SMA200.
Campbells Co (NASDAQ: CPB) currently have 298.00M outstanding shares and institutions hold larger chunk of about 58.33% of that.
The stock has a current market capitalization of $9.30B and its 3Y-monthly beta is at 0.10. PE ratio of stock for trailing 12 months is 20.60, while it has posted earnings per share of $1.51 in the same period. It has Quick Ratio of 0.33 while making debt-to-equity ratio of 1.88. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for CPB, volatility over the week remained 1.75% while standing at 1.10% over the month.
Stock’s fiscal year EPS is expected to drop by -4.91% while it is estimated to decrease by -3.50% in next year. EPS is likely to shrink at an annualized rate of -0.86% for next 5-years, compared to annual growth of 15.98% made by the stock over the past 5-years.
Coverage by UBS stated Campbells Co (CPB) stock as a Sell in their note to investors on April 23, 2025, suggesting a price target of $36 for the stock. On March 17, 2025, Consumer Edge Research Downgrade their recommendations, while on March 06, 2025, JP Morgan Downgrade their ratings for the stock with a price target of $37. Stock get an Overweight rating from Piper Sandler on November 14, 2024.
